Dr. Marc Bonten is Professor of clinical microbiology at University Medical Centre Utrecht in Utrecht, The Netherlands. He obtained his PhD (“the role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia, 1994) at the Maastricht University, the Netherlands.
He started his career as a registered internist in 2000, specialized in infectious disease since 2002 and became a clinical microbiologist in 2008 for the University Medical Center Utrecht, the Netherlands. As of August 2008 he’s head of the department Medical Microbiology and leading the research group of infectious Disease Epidemiology at the Julius Center of Health Sciences and Primary Care, both at the UMC Utrecht, where he operates as professor in molecular epidemiology and infectious diseases. In July 2015 he got appointed as scientific advisor for Antimicrobial Resistance at the National Institute of Health and Environment as well as the Center for Infectious Disease Control, in the Netherlands.
He was appointed as chairman for the Infection & Immunity Focus Program of the UMC Utrecht, on the editorial board of Intensive Care Medicine (2008-2012), and served on several Scientific Advisory Boards (JPI-AMR, SWAB). He received the VICI laureate in 2006 from the Dutch Science Association, PI of the CAPiTA study (investigator-initiated study funded by Wyeth, later Pfizer), coordinator of the EU-funded project R-GNOSIS and scientific coordinator of the IMI-funded consortiums COMBACTE-NET, COMBACTE-CARE, COMBACTE-MAGNET and COMBACTE-CDI. For his research efforts he was awarded with the Excellence Award of the European Society of Clinical Microbiology and Infectious Diseases in May 2015.